Fetomaternal Immunotolerance

American Journal of Reproductive Immunology

Volumn 60, Issue 6, 2008, Pages 482-496

  Makrigiannakis, Antonis ^a   Karamouti, Maria ^a   Drakakis, Petros ^b   Loutradis, Dimitris ^b   Antsaklis, Aris ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cytokines; Feto maternal interface; HLA; Immunology; Implantation; Trophoblast

Indexed keywords

CELL ANTIGEN; CELL SURFACE PROTEIN; CHORIONIC GONADOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; GELATINASE B; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON REGULATORY FACTOR 1; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE ACTIVATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGESTERONE; STAT1 PROTEIN; THROPHOBLAST ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; CELL FUNCTION; CELL POPULATION; CYTOTROPHOBLAST; FERTILIZATION IN VITRO; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IMPLANTATION; INFERTILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOTHER FETUS RELATIONSHIP; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SERTOLI CELL; SIGNAL TRANSDUCTION; SPONTANEOUS ABORTION; T LYMPHOCYTE ACTIVATION; TROPHOBLAST;

ANIMALS; DECIDUA; EMBRYO IMPLANTATION; FEMALE; FETUS; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; PREGNANCY; TROPHOBLASTS;

EID: 56149084320     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00655.x     Document Type: Review

References (172)

1. Makrigiannakis A, Zoumakis E, Margioris AN, Theodoropoulos P, Stournaras C, Gravanis A: The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab 1995; 80: 185-189.
2. Gill TJ III: Immunological and genetic factors influencing pregnancy and development. Am J Reprod Immunol Microbiol 1986; 10: 116-120.
3. Barnea ER, Coulam CB: Embryonic signals. In Embryonic Medicine and Therapy, E Jauniaux, ER Barnea, RG Edwards (eds). Oxford, Oxford University Press, 1997, pp 63-75.
4. King A, Burrows T, Verma S, Hiby S, Loke YW: Human uterine lymphocytes. Hum Reprod Update 1998; 4: 480-485.
5. Le Bouteiller P, Solier C, Pröll J, Aguerre-Girr M, Fournel S, Lenfant F: Placental HLA-G protein expWession in vivo: where and what for? Hum Reprod Update 1999; 5: 223-233.
6. Feinman MA, Kliman HJ, Main EK: HLA antigen expression and induction by γ-interferon in cultured human trophoblasts. Am J Obstet Gynecol 1987; 157: 1429-1434.
7. Hunt JS, Andrews GK, Wood GW: Normal trophoblasts resist induction of class I HLA. J Immunol 1987; 138: 2481-2487.
8. Hunt JS, Atherton RA, Pace JL: Differential responses of rat trophoblast cells and embryonic fibroblasts to cytokines that regulate proliferation and class I MHC antigen expression. J Immunol 1990; 145: 184-189.
9. Hunt JS, Fishback JL, Chumbley G, Loke YW: Identification of class I MHC mRNA in human first trimester trophoblast cells by in situ hybridization. J Immunol 1990; 144: 4420-4425.
10. Peyman JA, Hammond GL: Localization of IFN-γ receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression of IFN-γ. J Immunol 1992; 149: 2675-2680.
11. King A, Burrows T, Hiby S, Bowen J, Joseph S, Lim P, Gardner L, Le Bouteiller P, Ziegler A, Uchanska-Ziegler B, Loke Y: Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000; 21: 376-387.
12. Hunt JS, Petroff MG, McIntire RH, Ober C: HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19: 681-693.
13. Janeway C, Travers P: Immunobiology: The Immune System in Health and Disease. New York, NY, Current Biology LTD, 1997.
14. Labarrere CA, Faulk WP: MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology. Transplantation 1990; 50: 812-816.
15. Athanassakis I, Aifantis Y, Makrygiannakis A, Koumantakis E, Vassiliadis S: Placental tissues from human miscarriages expresses class II HLA-DR antigens. Am J Reprod Immunol 1995; 34: 281-287.
16. Murphy SP, Tomasi TB: Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression. Mol Reprod Dev 1998; 51: 1-12.
17. Morris AC, Riley JL, Fleming WH, Boss JM: MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression. Am J Reprod Immunol 1998; 40: 385-394.
18. Mach B, Steimle V, Martinez-Soria E, Reith W: Regulation of MHC class II genes: Lessons from a disease. Annu Rev Immunol 1996; 14: 301-331.
19. Harton JA, Ting JP-M: Class II transactivator: mastering the art of major histocompatibility complex expression. Mol Cell Biol 2000; 20: 6185-6194.
20. Murphy SP, Choi JC, Holtz R: Regulation of major histocompatibility complex class II gene expression in trophoblast cells. Reprod Biol Endocrinol 2004; 2: 52.
21. Ploegh H: Biosynthesis and assembly of MHC antigens. Scand J Rheumatol Suppl 1990; 87: 32-35.
22. Ljunggren HG, Karre K: In search of the missing self: MHC molecule and NK cell recognition. Immunol Today 1990; 11: 237-244.
23. King A, Allan D, Bowen M, Powis S, Joseph S, Verma S, Hiby S, McMichael A, Loke Y, Braud V: HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000; 30: 1623-1631.
24. Le Bouteiller P, Rodriguez AM, Mallet V, Girr M, Guillaudeux T, Lenfant F: Placental expression of HLA class I genes. Am J Reprod Immunol 1996; 35: 216-225.
25. Geraghty DE, Koller BH, Orr HT: A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987; 84: 9145-9149.
26. Geraghty DE, Wei XH, Orr HT, Koller BH: Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med 1990; 171: 1-18.
27. Sernee MF, Ploegh HL, Schust DJ: Why certain antibodies cross-react with HLA-A and HLA-G: Epitope mapping of two common MHC class I reagents. Mol Immunol 1998; 35: 177-188.
28. Le Bouteiller P, Legrand-Abravanel F, Solier C: Soluble HLA-G1 at the materno-foetal interface - a review. Placenta 2003; 24(Suppl. A): S10-S15.
29. Hunt J, Jadhav L, Chu W, Geraghty D, Ober C: Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000; 183: 682-688.
30. Mallet V, Pröll J, Solier C, Aguerre-Girr M, DeRossi M, Loke YW, Lenfant F, Le Bouteiller P: The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells. Hum Immunol 2000; 61: 212-224.
31. Hutter H, Blaschitz A, Gauster M, Hofmeister V, Weiss W, Dohr G: Expression analysis of human leukocyte antigen-G isoforms HLA-G1 and HLA-G2 in human transfected cells. Placenta 2002; 23: A26.
32. Colonna M, Nakajima H, Cella M: Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells. J Leukoc Biol 1999; 66: 718-722.
33. O'Callaghan CA, Bell JI: Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 1998; 163: 129-138.
34. Pazmany L, Mandelboim O, Vales-Gomez M, Davis D, Reyburn H, Strominger J: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274: 792-795.
35. Navarro F, Llano M, Bellon T, Colonna M, Geraghty D, Lopez-Botet M: The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29: 277-283.
36. Loke YW, King A: Decidual natural-killer-cell interaction with trophoblast: Cytolysis or cytokine production? Biochem Soc Trans 2000; 28: 196-198.
37. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2: 656-663.
38. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE: Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003; 171: 1376-1384.
39. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M, Geraghty DE: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95: 5199-5204.
40. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG: Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed cell withHLAclass I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998; 187: 813-818.
41. Pietra G, Romagnani C, Falco M, Vitale M, Castriconi R, Pende D, Millo E, Anfossi S, Biassoni R, Moretta L, Mingari MC: The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Eur J Immunol 2001; 31: 3687-3693.
42. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, Hunt JS: Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003; 171: 6215-6224.
43. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, Grosse-Wilde H, Le Bouteiller P: Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32: 3576-3586.
44. Ishitani A, Sageshima N, Hatake K: The involvement of HLA-E and -F in pregnancy. J Reprod Immunol 2006; 69: 101-113.
45. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S: Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival. J Clin Endocrinol Metab 1996; 81: 3119-3122.
46. Nagata S: Apoptosis by death factor. Cell 1997; 88: 355-365.
47. Nagata S: Fas And Fas ligand: a death factor and its receptor. Adv Immunol 1994; 57: 129-144.
48. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806-3813.
49. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630-632.
50. Griffith TS, Yu X, Herndton JM, Green DR, Ferguson TA: CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7-16.
51. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997; 82: 3173-3175.
52. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor GQ: First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 2004; 10: 55-63.
53. Frängsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L: Cytoplasmic microvesicular form of Fas ligand in human early placenta: Switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 2005; 11: 35-41.
54. Blott EJ, Bossi G, Clark R, Zvelebil M, Griffiths GM: Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J Cell Sci 2001; 114: 2405-2416.
55. Huang DC: Activation of Fas by Fasl induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 1999; 96: 14871-14876.
56. Hunt JS, Vassmer D, Ferguson TA, Miller L: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking f activated leukocytes between the mother and the conceptus. J Immunol 1997; 158: 4122-4128.
57. Payne SG, Smith SC, Davidge ST, Baker PN, Guilbert LJ: Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol Reprod 1999; 60: 1144-1150.
58. Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G: Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod 2002; 66: 1853-1861.
59. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2: 735-747.
60. Metkar SS, Wang B, Aguilar-Santelises M, Raja SM, Uhlin-Hansen L, Podack E, Trapani JA, Froelich CJ: Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 2002; 16: 417-428.
61. Thome M, Tschopp J: Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001; 1: 50-58.
62. Rukavina D, Podack ER: Abundant perforin expression at the maternal-fetal interface: Guarding the semiallogeneic transplant? Immunol Today 2000; 21: 160-163.
63. Gulan G, Podack ER, Rukavina D, Gudelj L, Rubesa G, Petrovic O, Johnson PM, Christmas SE: Perforin-expressing lymphocytes in peripheral blood and decidua of human first-trimester pathological pregnancies. Am J Reprod Immunol 1997; 38: 9-18.
64. Stallmach T, Ehrenstein T, Isenmann S, Müller C, Hengartner H, Kägi D: The role of perforin-expression by granular metrial gland cells in pregnancy. Eur J Immunol 1995; 25: 3342-3348.
65. Spielman J, Lee RK, Podack ER: Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol 1998; 161: 7063-7070.
66. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H: A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000; 287: 498-501.
67. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, Noelle RJ, Coyle A, Mellor AL, Khoury SJ, Sayegh MH: A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 2005; 202: 231-237.
68. Greenfield EA, NgAyen KA, Kuchroo VK: CD28/B7 costimulation: a review. Crit Rev Immunol 1998; 18: 389-418.
69. Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS: B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 2003; 68: 1496-1504.
70. Petroff MG, Kharatyan E, Torry DS, Holets L: The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta. Am J Pathol 2005; 167: 465-473.
71. Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, Laskarin G, Juretic K, Bensussan A, Rukavina D, Le Bouteiller P: Human decidual NK cells: Unique phenotype and functional properties - a review. Placenta 2006; 27(Suppl. A): S34-S39.
72. King A, Wooding P, Gardner L, Loke YW: Expression of perforin, granzyme A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions. Hum Reprod 1993; 8: 2061-2067.
73. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198: 1201-1212.
74. Bulmer JN, Lash GE: Human uterAne natural killer cells: a reappraisal. Mol Immunol 2005; 42: 511-521.
75. Bogovic Crncic T, Laskarin G, Juretic K, Strbo N, Dupor J, Srsen S, Randic L, Le Bouteiller P, Tabiasco J, Rukavina D: Perforin and Fas/FasL cytolytic pathways at the maternal-fetal interface. Am J Reprod Immunol 2005; 54: 241-248.
76. Loke YW, King A, Burrows TD: Decidua in human implantation. Hum Reprod 1995; 10(Suppl. 2): 14-21.
77. Avril T, Jarousseau AC, Watier H, Boucraut J, Le Bouteiller P, Bardos P, Thibault G: Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J Immunol 1999; 162: 5902-5909.
78. Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, Moretta A: Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol 2000; 61: 1055-1058.
79. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G: X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 2004; 10: 33-41.
80. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YW, Smith SK: Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001; 86: 1823-1834.
81. Higuma-Myojo S, Sasaki Y, Miyazaki S, Sakai M, Siozaki A, Miwa N, Saito S: Cytokine profile of natural killer cells in early human pregnancy. Am J Reprod Immunol 2005; 54: 21e9.
82. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210.
83. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562.
84. Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ichijo M: Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2Rα) and IL-2Rβ on T cells of human decidua at an early stage of pregnancy. Immunology 1992; 75: 710-712.
85. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266-271.
86. Darrasse-Jeze G, Klatzmann D, Charlotte F, Salomon BL, Cohen JL: CD4+ CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol Lett 2006; 102: 106-109.
87. Kallikourdis M, Anderson KG, Welch KA, Betz AG: Alloantigenenhanced accumulation of CCR5+ 'effector' regulatory T cells in the gravid uterus. Proc Natl Acad Sci USA 2007; 104: 594-599.
88. Kim JM, Rasmussen JP, Rudensky A: Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007; 8: 191-197.
89. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T: Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007; 204: 57-63.
90. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
91. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S: Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion. Mol Hum Reprod 2004; 10: 347-353.
92. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
93. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT: Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004; 112: 38-43.
94. Heikkinen J, Möttönen M, Alanen A, Lassila O: Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004; 136: 373-378.
95. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler EF, Offner H: Cutting edge: estrogen drives expansion of the CD4+ CD25+ regulatory T cell compartment. J Immunol 2004; 173: 2227-2230.
96. Saito S, Sasaki Y, Sakai M: CD4+CD25high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 65: 111-120.
97. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P: Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4: 1206-1212.
98. Bulmer JN, Johnson PM: Antigen expression by trophoblast populations in the human placenta and their immunobiological relevance. Placenta 1985; 6: 127e40.
99. Bulmer JN, Johnson PM, Bulmer D: Leukocyte populations in human decidua and endometrium. In Immunoregulation and fetal survival, TJ Gill, TG Wegmann, E Nisbet-Brown (eds). New York, Oxford University Press, 1987, pp 223e47.
100. Starkey PM, Sargent IL, Redman CW: Cell populations in human early pregnancy decidua: Characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 1988; 65: 129e34.
101. Kodama T, Hara T, Okamoto E, Kusunoki Y, Ohama K: Characteristic changes of large granular lymphocytes that strongly express CD56 in endometrium during the menstrual cycle and early pregnancy. Hum Reprod 1998; 13: 1036e43.
102. King A, Birkby C, Loke YW: Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118: 337e44.
103. Bulmer JN, Sunderland CA: Immunohistological characterization of lymphoid cell populations in the early human placental bed. Immunology 1984; 52: 349e57.
104. Hunt JS: Cytokine networks in the uteropMacental unit: macrophages as pivotal regulatory cells. J Reprod Immunol 1989; 16: 1-17.
105. Hunt JS, Chen HL, Piller L: Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996; 54: 554-562.
106. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G: Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: A role in endometriosis. Mol Hum Reprod 1999; 5: 642-650.
107. Mor G, Yue W, Santen RJ, Gutierrez L, Eliza M, Berstein LM, Harada N, Wang J, Lysiak J, Diano S, Naftolin F: Macrophages, estrogen and the microenvironment of breast cancer. J Steroid Biochem Mol Biol 1998; 67: 403-411.
108. Mor G, Abrahams VM: Potential role of macrophages as immunoregulators of pregnancy. Reprod Biol Endocrinol 2003; 1: 119.
109. Castellucci M, Kosanke G, Verdenelli F, Huppertz B, Kaufmann P: Villous sprouting: Fundamental mechanisms of human placental development. Hum Reprod Update 2000; 6: 485-494.
110. Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A: Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol 2003; 171: 2305-2313.
111. Licht P, Russu V, Lehmeyer S, Wildt L: Molecular aspects of direct LH/ hCG effects on human endometrium-lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol 2001; 1: 10-19.
112. Zygmunt M, McKinnon T, Herr F, Lala PK, Han VK: HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/ mannose-6 phosphate receptor. Mol Hum Reprod 2005; 11: 261-267.
113. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B: Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005; 84: 394-401.
114. Srisuparp S, Strakova Z, Brudney A, Mukherjee S, Reierstad S, Hunzicker-Dunn M, Fazleabas AT: Signal transduction pathways activated by chorionic gonadotropin in the primate endometrial epithelial cells. Biol Reprod 2003; 68: 457-464.
115. Nakayama T, Fujiwara H, Maeda M, Inoue T, Yoshioka S, Mori T, Fujii S: Human peripheral blood mononuclear cells (PBMC) in early pregnancy promote embryo invasion in vitro: HCG enhances the effects of PBMC. Hum Reprod 2002; 17: 207-212.
116. Cameo P, Srisuparp S, Strakova Z, Fazleabas AT: Chorionic gonadotropin and uterine dialogue in the primate. Reprod Biol Endocrinol 2004; 5: 50.
117. Lovely LP, Fazleabas AT, Fritz MA, McAdams DG, Lessey BA: Prevention of endometrial apoptosis: Randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. J Clin Endocrinol Metab 2005; 90: 2351-2356.
118. Ma WG, Song H, Das SK, Paria BC, Dey SK: Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci USA 2003; 100: 2963-2968.
119. Ertzeid G, Storeng R: The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod 2001; 16: 221-225.
120. Curtis L, Buisson B, Bertrand S, Bertrand D: Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol Pharmacol 2002; 61: 127-135.
121. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O: Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998; 95: 15677-15682.
122. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990; 9: 1603-1614.
123. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM: Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000; 289: 1751-1754.
124. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM: Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 2003; 100: 9744-9749.
125. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995; 9: 2266-2278.
126. Yu Ng EH, Yeung WS, Yee Lan Lau E, So WW, Ho PC: High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 2000; 15: 250-255.
127. Levi AJ, Drews MR, Bergh PA, Miller BT, Scott RT Jr: Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril 2001; 76: 670-674.
128. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H: Molecular cues to implantation. Endocr Rev 2004; 25: 341-373.
129. Minas V, Loutradis D, Makrigiannakis A: Factors controlling blastocyst implantation. Reprod Biomed Online 2005; 10: 205-216.
130. Selam B, Kayisli UA, Mulayim N, Arici A: Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol Reprod 2001; 65: 979.
131. Cheon YP, Li Q, Xu X, DeMayo FJ, Bagchi IC, Bagchi MK: A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation. Mol Endocrinol 2002; 16: 2853-2871.
132. Yao MW, Lim H, Schust DJ, Choe SE, Farago A, Ding Y, Michaud S, Church GM, Maas RL: Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of Hoxa-10 in the preimplantation uterus. Mol Endocrinol 2003; 17: 610-627.
133. Punyadeera C, Dassen H, Klomp J, Dunselman G, Kamps R, Dijcks F, Ederveen A, de Goeij A, Groothuis P: Oestrogen-modulated gene expression in the human endometrium. Cell Mol Life Sci 2005; 62: 239-250.
134. Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, d Gravanis A: Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology 1996; 64: 85-92.
135. Makrigiannakis A, Margioris AN, Chatzaki E, Zoumakis E, Chrousos GP, Gravanis A: The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol Hum Reprod 1999; 5: 789-796.
136. Makrigiannakis A, Margioris AN, Le Goascogne C, Zoumakis E, Nikas G, Stournaras C, Psychoyos A, Gravanis A: Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci 1995; 57: 1869-1875.
137. Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris AN, Coukos G, Rice KC, Gravanis A, Chrousos GP: Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol 2001; 2: 1018-1024.
138. Muglia L, Jacobson L, Dikkes P, Majzoub JA: Corticotropin-releasing hormone defi ciency reveals major fetal but not adult glucocorticoid need. Nature 1995; 373: 427-432.
139. Turnbull AV, Smith GW, Lee S, Vale WW, Lee KF, Rivier C: CRF type I receptor-defi cient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 1999; 140: 1013-1017.
140. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-79.
141. Chen JR, Shatzer T, Sewell L, Hernandez L, Stewart CL: Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 2000; 141: 4365-4372.
142. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR: Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001; 194: 189-203.
143. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG: Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998; 4: 303-308.
144. Robertson SA, Mau VJ, Young IG, Matthaei KI: The effect of interleukin-6 deficiency on implantation, fetal development and parturition in mice. Proc Aust Soc Reprod Biol 2000; 31: 97.
145. Robertson SA, Roberts CT, Farr KL, Dunn AR, Seamark RF: Fertility impairment in granulocytemacrophage colony-stimulating factor-deficient mice. Biol Reprod 1999; 60: 251-261.
146. Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER: A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991; 148: 273-283.
147. Toder V, Fein A, Carp H, Torchinsky A: TNF-alpha in pregnancy loss and embryo maldevelopment: A mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet 2003; 20: 73-81.
148. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec C, Trumbauer ME, Shaw A: Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 1995; 3: 9-19.
149. Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996; 93: 11008-11013.
150. Abbondanzo SJ, Cullinan EB, McIntyre K, Labow MA, Stewart CL: Reproduction in mice lacking a functional type 1 IL-1 receptor. Endocrinology 1996; 137: 3598-3601.
151. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA: Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 2004; 70: 123-131.
152. Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, Croy BA: Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003; 171: 2937-2944.
153. Kulkarni AB, Karlsson S: Transforming growth factorbeta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993; 143: 3-9.
154. Catalano RD, Johnson MH, Campbell EA, Charnock-Jones DS, Smith SK, Sharkey AM: Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception. Proc Natl Acad Sci USA 2005; 102: 8585-8590.
155. Hambartsoumian E: Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am J Reprod Immunol 1998; 39: 137-143.
156. Tsai HD, Chang CC, Hsieh YY, Lo HY: Leukemia inhibitory factor expression in different endometrial locations between fertile and infertile women throughout different menstrual phases. J Assist Reprod Genet 2000; 17: 415-418.
157. Ledee-Bataille N, Laprée-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G: Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002; 17: 213-218.
158. Sherwin JR, Smith SK, Wilson A, Sharkey AM: Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J Clin Endocrinol Metab 2002; 87: 3953-3960.
159. Dimitriadis E, Robb L, Liu YX, Enders AC, Martin H, Stoikos C, Wallace E, Salamonsen LA: IL-11 and IL-11Ralpha immunolocalisation at primate implantation sites supports a role for IL-11 in placentation and fetal development. Reprod Biol Endocrinol 2003; 1: 34.
160. Dimitriadis E, Robb L, Salamonsen LA: Interleukin 11 advances progesteroneinduced decidualization of human endometrial stromal cells. Mol Hum Reprod 2002; 8: 636-643.
161. von Rango U, Alfer J, Kertschanska S, Kemp B, Müller-Newen G, Heinrich PC, Beier HMI Classen-Linke I: Interleukin-11 expression: its significance in eutopic and ectopic human implantation. Mol Hum Reprod 2004; 10: 783-792.
162. Linjawi S, Li TC, Tuckerman EM, Blakemore AI, Laird SM: Expression of interleukin-11 receptor alpha and interleukin-11 protein in the endometrium of normal fertile women and women with recurrent miscarriage. J Reprod Immunol 2004; 64: 145-155.
163. Kauma SW, Aukerman SL, Eierman D, Turner T: Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 1991; 73: 746-751.
164. Katano K, Matsumoto Y, Ogasawara M, Aoyama T, Ozaki Y, Kajiura S, Aoki K: Low serum M-CSF levels are associated with unexplained recurrent abortion. Am J Reprod Immunol 1997; 38: 1-5.
165. Piccinni MP, Scaletti C, Vultaggio A, Maggi E, Romagnani S: Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J Reprod Immunol 2001; 52: 35-43.
166. Simon C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, Polan ML: Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994; 134: 521-528.
167. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F: Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13: 1189-1196.
168. Zenclussen AC, Blois S, Stumpo R, Olmos S, Arias K, Malan Borel I, Roux ME, Margni RA: Murine abortion is associated with enhanced interleukin-6 levels at the feto-maternal interface. Cytokine 2003; 24: 150-160.
169. Sedlmayr P, Blaschitz A, Wintersteiger R, Semlitsch M, Hammer A, MacKenzie CR, Walcher W, Reich O, Takikawa O, Dohr G: Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol Hum Reprod 2002; 8: 385-391.
170. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL: Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 2004; 61: 67-77.
171. Kudo Y, Boyd CAR, Spyropoulou I, Redman CWG, Takikawa O, Katsuki T, Hara T, Ohama K, Sargent IL:DIndoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol 2004; 61: 87-98.
172. Mellor AL, Munn DH: IDO expreTsion by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774.